Cwm LLC lifted its holdings in shares of Azenta, Inc. (NASDAQ:AZTA – Get Rating) by 43.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,012 shares of the company’s stock after buying an additional 306 shares during the quarter. Cwm LLC’s holdings in Azenta were worth $43,000 as of its most recent SEC filing.
Several other large investors have also made changes to their positions in the business. Glassman Wealth Services purchased a new stake in shares of Azenta during the second quarter worth approximately $25,000. Quadrant Capital Group LLC purchased a new stake in shares of Azenta during the second quarter worth approximately $26,000. Castle Wealth Management LLC purchased a new stake in shares of Azenta during the second quarter worth approximately $34,000. Assetmark Inc. purchased a new stake in Azenta in the 2nd quarter valued at $39,000. Finally, Tompkins Financial Corp purchased a new stake in Azenta in the 2nd quarter valued at $43,000. 96.42% of the stock is owned by institutional investors and hedge funds.
Azenta Trading Down 1.4 %
NASDAQ AZTA opened at $55.75 on Friday. The stock has a market cap of $3.85 billion, a PE ratio of 1.97 and a beta of 1.61. Azenta, Inc. has a twelve month low of $37.61 and a twelve month high of $93.39. The stock has a fifty day simple moving average of $58.83 and a 200-day simple moving average of $55.80.
Wall Street Analysts Forecast Growth
AZTA has been the subject of several analyst reports. KeyCorp dropped their target price on Azenta from $90.00 to $70.00 and set an “overweight” rating for the company in a report on Monday, October 24th. Needham & Company LLC upped their target price on Azenta from $74.00 to $78.00 and gave the company a “buy” rating in a report on Tuesday, November 15th. TheStreet upgraded Azenta from a “d+” rating to a “c-” rating in a report on Tuesday, December 13th. Finally, Stephens upped their target price on Azenta from $60.00 to $65.00 in a report on Thursday, November 17th. Four analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $72.60.
Azenta, Inc is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples.
- Get a free copy of the StockNews.com research report on Azenta (AZTA)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving ’23 Growth
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.